Search research articles
Contact Us
Filters
Showing results (81-90 of 387) with videos related to
Page
of 39
Sort By:
Psychiatry Investigation
|
March 23, 2017
Relationship between Depression and Laryngopharyngeal Reflux
Young-Hoon Joo, Youn-Su Song, Chi-Un Pae
Expert Review of Clinical Pharmacology
|
January 14, 2014
Profile of paliperidone extended release: review of efficacy and safety data
Meera Narasimhan, Shilpa Srinivasan, Chi Un Pae, et al.
The Primary Care Companion for CNS Disorders
|
February 10, 2015
A double-blind, placebo-controlled, parallel-group pilot study of milnacipran for chronic radicular pain (sciatica) associated with lumbosacral disc disease
David M Marks, Chi-Un Pae, Ashwin A Patkar
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 27, 2009
Safety and antipsychotic efficacy of "forced" intramuscular olanzapine over five days: a case report
David M Marks, Matthew J Conner, Chi-Un Pae
Current Neuropharmacology
|
July 10, 2009
Triple reuptake inhibitors: the next generation of antidepressants
David M Marks, Chi-Un Pae, Ashwin A Patkar
Psychiatry Investigation
|
January 5, 2010
Triple reuptake inhibitors: a premise and promise
David M Marks, Chi-Un Pae, Ashwin A Patkar
Expert Opinion on Investigational Drugs
|
October 3, 2013
Omega-3 polyunsaturated fatty acids for major depressive disorder
Kuan-Pin Su, Sheng-Min Wang, Chi-Un Pae
International Journal of Psychiatry in Clinical Practice
|
June 18, 2014
Partial compliance with antipsychotics and its impact on patient outcomes
Meera Narasimhan, Chi Un Pae, Natasha Masand, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
September 12, 2013
Low-frequency, Repetitive Transcranial Magnetic Stimulation for the Treatment of Patients with Posttraumatic Stress Disorder: a Double-blind, Sham-controlled Study
Dong-Hyun Nam, Chi-Un Pae, Jeong-Ho Chae
Expert Opinion on Drug Safety
|
April 27, 2022
Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability
Michael D Kritzer, Chi-Un Pae, Prakash S Masand
Page
of 39
Search research articles
Search
Showing results (81-90 of 387) with videos related to
Sort By:
Page
of 39
Psychiatry Investigation
|
March 23, 2017
Relationship between Depression and Laryngopharyngeal Reflux
Young-Hoon Joo, Youn-Su Song, Chi-Un Pae
Expert Review of Clinical Pharmacology
|
January 14, 2014
Profile of paliperidone extended release: review of efficacy and safety data
Meera Narasimhan, Shilpa Srinivasan, Chi Un Pae, et al.
The Primary Care Companion for CNS Disorders
|
February 10, 2015
A double-blind, placebo-controlled, parallel-group pilot study of milnacipran for chronic radicular pain (sciatica) associated with lumbosacral disc disease
David M Marks, Chi-Un Pae, Ashwin A Patkar
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 27, 2009
Safety and antipsychotic efficacy of "forced" intramuscular olanzapine over five days: a case report
David M Marks, Matthew J Conner, Chi-Un Pae
Current Neuropharmacology
|
July 10, 2009
Triple reuptake inhibitors: the next generation of antidepressants
David M Marks, Chi-Un Pae, Ashwin A Patkar
Psychiatry Investigation
|
January 5, 2010
Triple reuptake inhibitors: a premise and promise
David M Marks, Chi-Un Pae, Ashwin A Patkar
Expert Opinion on Investigational Drugs
|
October 3, 2013
Omega-3 polyunsaturated fatty acids for major depressive disorder
Kuan-Pin Su, Sheng-Min Wang, Chi-Un Pae
International Journal of Psychiatry in Clinical Practice
|
June 18, 2014
Partial compliance with antipsychotics and its impact on patient outcomes
Meera Narasimhan, Chi Un Pae, Natasha Masand, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
September 12, 2013
Low-frequency, Repetitive Transcranial Magnetic Stimulation for the Treatment of Patients with Posttraumatic Stress Disorder: a Double-blind, Sham-controlled Study
Dong-Hyun Nam, Chi-Un Pae, Jeong-Ho Chae
Expert Opinion on Drug Safety
|
April 27, 2022
Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability
Michael D Kritzer, Chi-Un Pae, Prakash S Masand
Page
of 39